Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: George Mc Geary who wrote (668)	7/18/1998 10:15:00 AM
From: tktom	Respond to of 756

Frosty has done everything he can to move this stock. Slashed employment from 9,000 to 4,500. Sold everything that is not biotechnology related (Even the personal care division for $ 85 Million, which I believe will be credited in the third quarter). And the only debt is the $ 65 million of the 6.5 % convertible. Mr. Market is still not convinced. There is a massive creditability problem. Now if only they can deliver some new cancer products in the near future (which will be their only MAIN new product area), this could be the fuel to launch this rocketship!